%D8%A8%D8%B1%D8%A7%D9%8A%D8%A7%D9%86_%D9%83%D8%A7%D8%A8%D9%8A%D9%84%D9%83%D8%A7%D8%A8%D8%B1%D8%A7%D9%8A%D9%86_%D9%83%D9%88%D8%A8%D9%8A%D9%84%D9%83%D8%A7%D8%A8%D8%B1%D8%A7%DB%8C%D8%A7%D9%86_%DA%A9%D8%A8%DB%8C%D9%84%DA%A9%D8%A7%D0%91%D1%80%D0%B0%D1%8F%D0%BD_%D0%9A%D0%B0%D0%B1%D1%8B%D0%BB%D0%BA%D0%B0%D0%91%D1%80%D0%B0%D0%B9%D1%8A%D0%BD_%D0%9A%D0%BE%D0%B1%D0%B8%D0%BB%D0%BA%D0%B0%E0%A6%AC%E0%A7%8D%E0%A6%B0%E0%A6%BE%E0%A6%AF%E0%A6%BC%E0%A6%BE%E0%A6%A8_%E0%A6%95%E0%A7%8B%E0%A6%AC%E0%A6%BF%E0%A6%B2%E0%A7%8D%E0%A6%95%E0%A6%BEBrian_KobilkaCategory:Brian_KobilkaBrian_KobilkaBrian_KobilkaBrian_KobilkaBrian_KobilkaBrian_KobilkaBrian_Kobilka%D8%A8%D8%B1%D8%A7%DB%8C%D8%A7%D9%86_%DA%A9%D8%A8%DB%8C%D9%84%DA%A9%D8%A7Brian_KobilkaBrian_KobilkaBrian_KobilkaBrian_Kobilka%D7%91%D7%A8%D7%99%D7%90%D7%9F_%D7%A7%D7%95%D7%91%D7%99%D7%9C%D7%A7%D7%94%E0%A4%AC%E0%A5%8D%E0%A4%B0%E0%A4%BE%E0%A4%AF%E0%A4%A8_%E0%A4%95%E0%A5%8B%E0%A4%AC%E0%A4%BF%E0%A4%95%E0%A4%BEBrian_KobilkaBrian_K._KobilkaBrian_Kent_KobilkaBrian_Kobilka%E3%83%96%E3%83%A9%E3%82%A4%E3%82%A2%E3%83%B3%E3%83%BB%E3%82%B3%E3%83%93%E3%83%AB%E3%82%AB%EB%B8%8C%EB%9D%BC%EC%9D%B4%EC%96%B8_%EC%BD%94%EB%B9%8C%EC%B9%B4Brianus_KobilkaBraiens_KobilkaBrian_KobilkaBrian_Kent_KobilkaBrian_KobilkaBrian_KobilkaBrian_Kent_KobilkaBrian_Kobilka%D8%A8%D8%B1%DB%8C%D8%A7%D9%86_%DA%A9%D9%88%D8%A8%D9%84%DA%A9%D8%A7Brian_KobilkaBrian_K._Kobilka%D0%9A%D0%BE%D0%B1%D0%B8%D0%BB%D0%BA%D0%B0,_%D0%91%D1%80%D0%B0%D0%B9%D0%B0%D0%BDBrian_Kobilka
about
sameAs
P185
Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in miceActivation and allosteric modulation of a muscarinic acetylcholine receptorA novel interaction between adrenergic receptors and the alpha-subunit of eukaryotic initiation factor 2BDosage-dependent switch from G protein-coupled to G protein-independent signaling by a GPCRIntracellular targeting and trafficking of thrombin receptors. A novel mechanism for resensitization of a G protein-coupled receptorLigand-regulated internalization and recycling of human beta 2-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptorsCloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptorHeterozygous alpha 2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists.Structure of a nanobody-stabilized active state of the β(2) adrenoceptorcDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factorStructure and function of an irreversible agonist-β(2) adrenoceptor complexStructure of the human M2 muscarinic acetylcholine receptor bound to an antagonistCloning of the cDNA for the human beta 1-adrenergic receptorCrystal structure of the β2 adrenergic receptor-Gs protein complexCloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtypeHigh-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptorStructure-based discovery of opioid analgesics with reduced side effects.Muscarinic acetylcholine receptor X-ray structures: potential implications for drug developmentHigh-density grids for efficient data collection from multiple crystalsGoniometer-based femtosecond crystallography with X-ray free electron lasers.Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptorCrystal structure of the human beta2 adrenergic G-protein-coupled receptorN-Terminal T4 Lysozyme Fusion Facilitates Crystallization of a G Protein Coupled ReceptorHigh-resolution crystal structure of human protease-activated receptor 1Structure and dynamics of the M3 muscarinic acetylcholine receptorStructure of active β-arrestin-1 bound to a G-protein-coupled receptor phosphopeptideCrystal structure of the µ-opioid receptor bound to a morphinan antagonistStructure of the δ-opioid receptor bound to naltrindoleAdrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobodyCovalent agonists for studying G protein-coupled receptor activationThe genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptorHuman beta 1- and beta 2-adrenergic receptors: structurally and functionally related receptors derived from distinct genesVisualization of arrestin recruitment by a G-protein-coupled receptorGPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor functionAntithetic regulation by beta-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway beta-agonist paradoxbetaAR signaling required for diet-induced thermogenesis and obesity resistanceTargeted disruption of the beta2 adrenergic receptor geneDifferential distribution of beta-adrenergic receptor subtypes in blood vessels of knockout mice lacking beta(1)- or beta(2)-adrenergic receptorsSignaling from beta1- and beta2-adrenergic receptors is defined by differential interactions with PDE4Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects
P50
Q24303396-AFE96C72-5D5C-4BE3-B849-B3CEC9D758E9Q24308061-1B66F669-DC19-4308-845D-106B3DF50BC3Q24319126-7BD7F6DF-DA09-45B2-A917-C9BF8FD54E87Q24336882-6FDD6384-474E-44FF-815F-07C81CE0923BQ24336999-3CC81212-0DCA-46D3-8820-3644DF5D224DQ24338468-6A65139D-E708-4A46-B747-036D6B2E38C7Q24339630-AF076961-AED3-4644-A753-84D24F328F08Q24535863-9B27D2EC-578F-4BB6-B759-63D8B14F7003Q24597139-60E2604C-D50A-42B7-A5CE-FDC2D7D0FFAEQ24619262-BF0BB470-43B2-40FA-804A-A3CA5FC8E040Q24620291-AABCED1B-F866-4E75-A17E-6E04A98C71D9Q24628686-F301A90E-4F86-4D42-89E6-7F3F1E8B20B5Q24633148-CCB43B0A-63A8-492A-9C64-5F77470AEE1FQ24635327-B74B9595-DC7A-4E05-B3FB-6859D5875268Q24650374-5AC3563F-AA37-4516-B978-D0EF738CF7FAQ24657484-07B8153B-1990-4108-9DF9-FBD794FBDB70Q26331003-988D4FFD-9BD9-41FF-9E79-FC92F4FF7933Q26999429-DDB97636-37A8-46B9-9413-E3699683FBC1Q27316862-1310AAFC-1C2C-4F5C-8DE0-7B6941C3870BQ27644521-54ABC28F-0A9C-4AE3-A944-23A72AB0A5E0Q27646733-4D1BFF6C-27DE-4355-9936-8CCE0C8E07E6Q27648868-516FEBC3-A3B0-4FBF-B260-118CD08EFB90Q27674422-BC63D78F-96BE-46F3-8207-A286DA2D894DQ27675402-CB817841-59D3-49EA-9565-DFF4796DCA6AQ27677433-8F60BC49-20BE-4969-ACD8-FA25B4E7C2A0Q27677473-04C2F1B3-6E45-433B-92F3-C1B4CEFDFD84Q27678133-D77B8968-4231-4994-A0E6-88AE16436E65Q27679153-48050AEC-8809-45F7-9A04-D45B0A6950F9Q27680016-8A04393D-05D9-4E61-941A-611BFCE2749BQ27684620-81A0261C-53F8-40FB-BA7C-D657ECA75F78Q28115183-8ED16C18-7856-4A4B-B0A7-06208B938ABCQ28236513-D9880469-3321-4BA9-8162-0D36318639D6Q28244290-2D6CCFB7-F4F2-4C92-8153-9D10DF74A9FCQ28254935-14BE374A-D673-4BFC-B905-C18947812BB1Q28507610-755206D9-160D-4842-A3FF-735A9A0C15C6Q28508047-6BEE5CA0-AF13-4387-BE34-921ECD3D92D3Q28510519-35B4CB78-BCD5-439B-A8E5-A83B1BF24888Q28513963-488A2B47-CC39-4FB0-86B2-9B25A7CB4DDDQ28590119-C0AC8418-10DA-438D-95F4-F9B8B5D6513EQ28592167-A46E30FB-C2EB-4AFD-BC41-F367072684E1
P50
description
Amerikaans biochemicus
@nl
US-amerikanischer Biochemiker und Nobelpreisträger
@de
biochimico statunitense
@it
chimiste américain
@fr
medical scientist
@en
американски учен
@bg
醫學家
@zh
name
Braiens Kobilka
@lv
Brajan Kobilka
@sr
Brian K. Kobilka
@id
Brian K. Kobilka
@ro
Brian Kent Kobilka
@io
Brian Kent Kobilka
@nds
Brian Kobilka
@ast
Brian Kobilka
@ca
Brian Kobilka
@cs
Brian Kobilka
@cy
type
label
Braiens Kobilka
@lv
Brajan Kobilka
@sr
Brian K. Kobilka
@id
Brian K. Kobilka
@ro
Brian Kent Kobilka
@io
Brian Kent Kobilka
@nds
Brian Kobilka
@ast
Brian Kobilka
@ca
Brian Kobilka
@cs
Brian Kobilka
@cy
altLabel
B K Kobilka
@en
B Kobilka
@en
B. K. Kobilka
@en
B. Kobilka
@en
Brian K Kobilka
@en
Brian K. Kobilka
@de
Brian K. Kobilka
@en
Brian K. Kobilka
@et
Brian K. Kobilka
@fi
Brian K. Kobilka
@fr
prefLabel
Braiens Kobilka
@lv
Brajan Kobilka
@sr
Brian K. Kobilka
@id
Brian K. Kobilka
@ro
Brian Kent Kobilka
@io
Brian Kent Kobilka
@nds
Brian Kobilka
@ast
Brian Kobilka
@ca
Brian Kobilka
@cs
Brian Kobilka
@cy